[HTML][HTML] Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

…, S Onderwater, B Jasperse, WV Vogel… - Nature …, 2021 - nature.com
Surgery for locoregionally advanced head and neck squamous cell carcinoma (HNSCC)
results in 30‒50% five-year overall survival. In IMCISION (NCT03003637), a non-randomized …

Comparison of five segmentation tools for 18f-fluoro-deoxy-glucose–positron emission tomography–based target volume definition in head and neck cancer

DAX Schinagl, WV Vogel, AL Hoffmann… - International Journal of …, 2007 - Elsevier
PURPOSE: Target-volume delineation for radiation treatment to the head and neck area
traditionally is based on physical examination, computed tomography (CT), and magnetic …

[HTML][HTML] The tubarial salivary glands: A potential new organ at risk for radiotherapy

…, JA Langendijk, LE Smeele, WV Vogel - Radiotherapy and …, 2021 - Elsevier
Introduction The presence of previously unnoticed bilateral macroscopic salivary gland
locations in the human nasopharynx was suspected after visualization by positron emission …

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques

…, TS Aukema, WV Vogel… - Breast cancer research …, 2012 - Springer
The aim of the present study was to investigate if 18F-fluorodeoxyglucose (18F-FDG) positron
emission tomography/computed tomography (PET/CT) outperforms conventional imaging …

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients

EGC Troost, WV Vogel, MAW Merkx… - Journal of nuclear …, 2007 - Soc Nuclear Med
Repopulation of clonogenic tumor cells is inversely correlated with radiation treatment
outcome in head and neck squamous cell carcinomas. A functional imaging tool to assess the …

Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II–III breast cancer

…, NS Russell, KGA Gilhuijs, WV Vogel… - European Journal of …, 2010 - Elsevier
PURPOSE: The aim of this prospective study was to assess the incidence of extra-axillary
lymph node involvement on baseline FDG PET/CT in patients with stage II–III breast cancer …

Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission

WV Vogel, A Guislain, P Kvistborg… - Journal of Clinical …, 2012 - ascopubs.org
Discussion To our knowledge, this is the first report of a patient developing pulmonary
sarcoidosis during ipilimumab treatment at the 3-mg/kg dose level, while complete regression of …

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques

TS Aukema, EJT Rutgers, WV Vogel… - European Journal of …, 2010 - Elsevier
PURPOSE: The aim of this study was to evaluate the impact of 18 F-fluorodeoxyglucose
positron-emission tomography/computed tomography (FDG PET/CT) on clinical management in …

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer

BB Koolen, KE Pengel, J Wesseling, WV Vogel… - The Breast, 2013 - Elsevier
Background Response monitoring with MRI during neoadjuvant chemotherapy (NAC) in
breast cancer is promising, but knowledge of breast cancer subtype is essential. The aim of the …

Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT

…, LE Smeele, RJJ van Es, R de Bree, WV Vogel - Oral surgery, oral …, 2018 - Elsevier
Objectives Prostate-specific membrane antigen (PSMA) positron emission tomography/computed
tomography (PET/CT) is used for detection and (re)staging of prostate cancer. However…